Medizinische Universität Graz - Research portal
-
Assoz. Prof. Priv.-Doz. Dr.med.univ. Martin Pichler
- Division of Oncology
- Head of Research Unit
- Non-Coding RNAs and Genome Editing in Cancer
- EMail: martin.pichler(at)medunigraz.at
- Tel: +43/316/385/3115
- MEDonline-Visitenkarte
- Externe ID's
- ORCiD: 0000-0002-8701-9462
Statistik Austria, science classification
- Oncology - (302055)
Scientific Expertise
- oncology
- molecular medicine
- MicroRNAs
- non-coding RNAs
- prognostic models
- kidney cancer
- colorectal cancer
- Genitourinary Cancer
- Gastrointestinal Cancer
- Melanoma
- Breast Cancer
- Lymphoma
- Sarcoma
- Lung and Esophagus cancer
Curr. Vitae
| 2021 | Deputy Speaker (Sektion Onkologie) Doc-School "Translational molecular and cellular Bioscience"" |
| 2021 | Vice-Speaker Research Area Cancer Research at the Medical University of Graz |
| 2020 -2021 | Certificate in Applied Biostatistics, Harvard, Boston, USA |
| 2019 | Visiting Professor (July-August 2019) at the University of Texas MD Anderson Cancer Center, TX, USA |
| 2019 -2021 | Master of Business Administration (MBA) Health Care Management, Vienna University of Economics and Business ("passed with honors" specialization: Cost-effectiveness analysis of cancer drugs) |
| 2019 | ÖAK-Diplom Palliativmedizin |
| 2019 | Programmdirektor Urogenital Cancer (Non-prostate) |
| 2018 -2021 | Adjunct Associate Professor at the Division of Cancer Medicine, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, USA (ranked No. 1 in cancer care in 2018, America’s Best Hospitals, U.S. News and World Report (ranked in the top two every year since 1990)) |
| 2018 | Visiting Professor (March-April 2018) at the UT MD Anderson Cancer Center, Houston, Tx, USA |
| 2018 | Adjunct Professor at the Central European Institute of Technology (CEITIC), Brno, Czechia (Host: Ondrej Slaby) |
| 2018 -2019 | Harvard Medical School (12 months), Boston, USA - High Impact Cancer Research (Special Tracks: Omics Technologies in Precision Medicine/Drug Development/Leadership) |
| 2018 -2019 | Basics in Palliative Care (23.5 ECTS) |
| 2018 | Listung im Dreier-Vorschlag im Berufungsverfahren für Hämatologie und Internistische Onkologie, Kepler Universitätsklinikum Linz |
| 2018 -2019 | Universitätslehrgang für Führungskräfte im Gesundheitssystem - UPGRADE (30 ECTS) |
| 2017 -2018 | Universitätskurs für Führungskräfte im Gesundheitssystem |
| 2016 | Visiting Professor (February-March 2016) at the UT MD Anderson Cancer Center, Houston, TX, USA |
| 2016 -2021 | Research Managing Director at the Division of Clinical Oncology |
| 2016 | Programmdirector Skin Cancer |
| 2015 -2018 | Adjunct Ass. Professor at the Division of Cancer Medicine, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, USA (ranked No. 1 in cancer care 2013 and 2015 , America’s Best Hospitals, U.S. News and World Report (ranked in the top two every year since 1990)) |
| 2015 | Associate Professor at the Medical University of Graz |
| 2015 | Habilitation im Fach "Innere Medizin" |
| 2013 | Internal Medicine |
| 2013 -2015 | Visiting Scientist at the Department of Experimental Therapeutics, Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, USA (No. 1 in cancer care 2013 and 2015, America’s Best Hospitals, U.S. News and World Report (ranked in the top two every year since 1990) |
| 2007 -2013 | MD |
| 2006 -2007 | Postdoc Fellowship at the Institute of Pathology |
| 2004 -2009 | Diploma in Molecular Microbiology |
| 2000 -2006 | M.D. graduation |
Awards
| 2020 | BiotechMed (BTM) Lab Rotation Program (Host and Mentor for Julia Teppan) |
| 2020 | BiotechMed (BTM) Lab Rotation Program (Host for Amar Balihodzic) |
| 2020 | Oral Best Submitted Abstract Spring Meeting Austrian Society for Hematology and Oncology (Senior author) |
| 2019 | FWF Hertha Firnberg-Programm (Mitantragsteller und Mentor, Projekt-Nummer T-1112) |
| 2019 | Best Poster Award Oncology - Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und medizinische Onkologie (Senior-author) |
| 2019 | Marshall Plan Scholarship (Mentor) |
| 2019 | Young Investigator Award Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und medizinische Onkologie (Senior-author) |
| 2019 | Poster Award at the Central European Meeting der Europäischen Gesellschaft für Urologie, Vienna (Seniorauthor) |
| 2019 | Maximilian Nitze Preis (Co-author) |
| 2018 | Best Presentation Award (2nd price) - Doctoral Day at the Medical University of Graz (Mentor and Senior Author) |
| 2018 | Best Abstract Award Frühjahrstagung der Österreichischen Gesellschaft für Onkologie (Presenting and Seniorauthor) |
| 2018 | Best Poster Award Oncology (Presenting and Seniorauthor) Frühjahrstagung der Österreichischen Gesellschaft für Hämato-Onkologie |
| 2017 | ÖGHO Young Investigator Award (First author) |
| 2017 | Wolfgang Denk Preis (First author) |
| 2017 | Most highly cited paper in "Oncogene" |
| 2017 | Marshall Plan Scholarship (Mentor) |
| 2017 | FWF Hertha Firnberg-Programm (Mitantragsteller und Mentor, Projekt-Nummer T-982) |
| 2017 | Beste Dissertation an der MUG 2017 (Mentor and Senior author) |
| 2017 | Best Poster Award Oncology Frühjahrstagung der ÖGHO Bregenz (Senior author) |
| 2016 | International Journal of Molecular Sciences 2016 Best Paper Award |
| 2015 | Anerkennungspreis Erwin Wenzl Preis (Supervisor) |
| 2015 | Sanofi Aventis Preis (Seniorauthor) |
| 2015 | Best talk International Student Congress (Supervisor) |
| 2015 | Diplomarbeitspreis der Wissenschaftlichen Gesellschaft der ÄrztInnen in der Steiermark (Erstbetreuer) |
| 2015 | OTMAR-PEISCHL-GEDENKPREIS (Seniorauthor) |
| 2014 | "Article of the Month" September 2014 in BJUI (Corresponding Author) |
| 2014 | Biomed Central Cancer category Research Award (Co-author) |
| 2014 | Wolfgang Denk Preis (Senior Author) |
| 2014 | Sanofi-Aventis Preis (Co-author) |
| 2014 | Stärkste Publikationsleistung 2012/2013 am Center of Medical Research, MUG (Kategorie: alle ProjektleiterInnen unter 40Jahren) |
| 2014 | BioMed Central Overall Research Award (Co-author) |
| 2014 | Best Poster Award 27th Annual Meeting of the European Musculo-Skeletal Oncology Society (Senior Author) |
| 2013 | Forscher des Jahres an der Medizinischen Universität Graz |
| 2013 | Posterpreis, 26th European Musculoskelettal Oncology Society Meeting in Göteborg, Schweden |
| 2013 | Peregrini Preis (Co-author) |
| 2013 | Sanofi-Aventis Preis (Erstauthor) |
| 2013 | Best Poster award in the session Renal tumour diagnosis: From new techniques to follow-up', 28th Annual EAU (European Association of Urology) Congress, Milan |
| 2012 | Posterpreis der ÖGHO für Onkologie |
| 2012 | Hans und Blanca Moser Preis fuer Translationale Forschung |
| 2012 | Posterpreis der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie |
| 2012 | Posterpreis der ÖGHO für Hämatologie |
| 2012 | Posterpreis der Österreichischen Gesellschaft für Innere Medizin |
| 2012 | Max Kade Fellowship of the Austrian Academy of Science granted for 12 months but not accepted due to competing interests with FWF Schroedinger fellowship |
| 2012 | FWF-Erwin-Schrödinger Stipendium |
| 2010 | Anerkennungspreis Steirische Krebshilfe |
| 2009 | Ing. Friedrich Schmiedl Preis |
| 2006 | Betreuer der MTA-Diplomarbeit des Jahres |
| 2005 | Hans und Blanca Moser Forschungsstipendium |
| 2004 | Hans und Blanca Moser Forschungsstipendium |
Appointments/Memberships in Professional Societies
| 2019 -2022 | Doctoral/PhD Board Masaryk University | Faculty of Medicine, Brno, Czechia
Board Member |
| 2019 -2050 | Alumni Club Harvard Medical School, Boston, USA Member |
| 2022 -2022 | Working Group on Poor Prognosis Cancers, French National Cancer Institute Working group Member |
| 2020 -2022 | AIO Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft Ordentliches Mitglied |
| 2018 -2022 | Qualitätszirkel CCC Subzentrum HAUT Member |
| 2016 -2022 | Österreichische Gesellschaft für Hämatologie und Onkologie (ÖGHO) Wissenschaftlicher Beirat |
| 2016 -2022 | GU connect group member Founding member |
| 2016 -2022 | BioTechMed-Graz Ordentliches Mitglied |
| 2010 -2022 | ESMO Membership |
| 2010 -2022 | ÖGIM - Österreichische Gesellschaft für Innere Medizin Mitglied |
| 2016 -2018 | Associate Faculty Member DK-MCD Associated Member |
| 2016 -2017 | Austrian Expert Panel for Molecular Cancer Profiling Founding Member |
Editorial board appointments for scientific journals
| 2019 -2021 | MEMO - MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY: Section Editor Uro-Oncology |
| 2017 -2021 | JOURNAL OF THORACIC DISEASE: |
| 2016 -2021 | NON-CODING RNA: Editorial Board |
| 2014 -2021 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES: Collection Editor |
| 2019 -2020 | CANCERS: |
| 2013 -2018 | CANCER CELL & MICROENVIRONMENT: Editorial Board |
| 2013 -2018 | JOURNAL OF KIDNEY CANCER AND VHL: Editorial Board |
Reviewer for scientific journals
Expert for appointment/habilitation procedures
| 2022 | Berufung: Gutachter: Paracelsus Privatuniversität Salzburg Tenure Track |
| 2021 | Habilitation: Gutachter: Masaryk University, Brno, Czechia |
| 2020 | Berufung: Gutachter: The UT MD Anderson Cancer Center, Houston, Tx Tenure Track Position Evaluation |
Reviewer/Expert funding organizations
| 2019 -2022 | Wilhelm Sander Stiftung - Germany |
| 2017 -2022 | Bürgermeisterfonds Wien - Austria |
| 2022 -2022 | European Research Council (ERC) Starting Grants - European Union |
| 2021 -2021 | Israel Science Foundation - Israel |
| 2021 -2021 | INSERM (Institut national de la santé et de la recherche médicale) - France |
| 2020 -2021 | Deutsche Forschungsgemeinschaft ( DFG )- Sonderforschungsbereich - Germany |
| 2020 -2020 | Swiss National Science Foundation - Switzerland |
| 2020 -2020 | PMU-FFF, Paracelsus Medical University Research Fund - Austria |
| 2019 -2019 | Fonds der Stadt Wien für Innovative Interdisziplinierte Krebsforschung - Austria |
| 2019 -2019 | Fulbright Commission - Austria |
| 2019 -2019 | Jubiläumsfonds der Österreichischen Nationalbank (ÖNB) - Austria |
| 2019 -2019 | Health Research Board - Ireland |
| 2018 -2018 | Czech Health Research Council - Czech Republic |
| 2017 -2017 | Dutch Research Council (NWO) - Netherlands |
| 2017 -2017 | Medical Research Council - United Kingdom |
| 2012 -2016 | Jubiläumsfond der Österr. Nationalbank, Österreich - Austria |
| 2016 -2016 | Deutsche Forschungsgemeinschaft - Germany |
| 2016 -2016 | Wellcome Trust - United Kingdom |
| 2015 -2015 | Cancer Research UK - United Kingdom |
| 2014 -2014 | Tiroler Wissenschaftsfonds (TWF) Amt der Tiroler Landesregierung - Austria |
| 2013 -2013 | Niederösterreichische Forschungs- und Bildungsges.m.b.H. (NFB) - Austria |
Reviewer/Expert organization
| 2020 | Gutachter Abstract Einreichungen Rubrik "Hodentumoren" DGHO Tagung 2020 |
| 2020 | Gutachter Ethikkommission der Stadt Wien |
| 2020 | Gutachter Diplomarbeit an der Paracelsus Medizinische Privatuniversität Salzburg |
| 2019 | Thesis Juror at the Martin-Luther-University Halle-Wittenberg, Germany |
| 2019 | CEITIC PhD Program Scientific Advisor |
| 2019 | International Clinical Research Center, St. Anne´s University Hospital Brno, Czechia Supervisory Board |
| 2017 | Ethikkommision MedUni Wien |
| 2016 | Habilitationsgutachter Medizinische Universität Graz |
| 2016 | Thesis Juror at Medical University of Vienna |
| 2016 | Research Mentor at the University of Notre Dame Notre Dame, IN, USA |
| 2015 | OEGHO Young Investigator Award |
| 2015 | Thesis Juror at the Faculty of Science - Cairo University, Giza, Egypt |
Organizer of scientific conferences, Chairs
| 2018 | Programm- und Organisationskomitees Wissenschaftliches Team, Jahrestagung der Deutschen, Österreichischen und Schweizer Gesellschaft für Hämatologie und Onkologie Mitglied Organisationskomitee |